Moneta Group Investment Advisors LLC Eli Lilly & CO Transaction History

Moneta Group Investment Advisors LLC

$9.24 Billion
Q3 2024

A detailed history of Moneta Group Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 10,857 shares of LLY stock, worth $8.64 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

10,857

Previous 11,040 1.66%

Holding current value

$8.64 Million

Previous $10 Million 3.77%

% of portfolio

0.1%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $141,301 - $175,683	-183 Reduced 1.66%	10,857 $9.62 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $1.89 Million - $2.37 Million	-2,607 Reduced 19.1%	11,040 $10 Million
Q1 2024 Aug 13, 2024	BUY	$592.2 - $792.28 $2.97 Million - $3.97 Million	5,017 Added 58.13%	13,647 $10.6 Million
Q4 2023 Feb 15, 2024	BUY	$525.19 - $619.13 $47,792 - $56,340	91 Added 1.07%	8,630 $5.03 Million
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $191,702 - $264,291	441 Added 5.45%	8,539 $4.59 Million
Q2 2023 Aug 15, 2023	SELL	$350.74 - $468.98 $114,341 - $152,887	-326 Reduced 3.87%	8,098 $3.8 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $727,495 - $854,408	2,342 Added 38.51%	8,424 $2.89 Million
Q4 2022 Feb 16, 2023	BUY	$321.55 - $374.67 $204,505 - $238,290	636 Added 11.68%	6,082 $2.23 Million
Q4 2022 Feb 16, 2023	SELL	$321.55 - $374.67 $1.75 Billion - $2.04 Billion	-5,440,580 Reduced 99.9%	5,446 $1.99 Million
Q4 2022 Feb 15, 2023	BUY	$321.55 - $374.67 $1.75 Billion - $2.04 Billion	5,440,731 Added 102752.24%	5,446,026 $1.99 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $20,160 - $22,975	-68 Reduced 1.27%	5,295 $1.71 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $7,525 - $8,836	27 Added 0.51%	5,363 $1.74 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $31,448 - $39,082	134 Added 2.58%	5,336 $1.53 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $2,923 - $3,627	13 Added 0.25%	5,202 $1.44 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $717,319 - $882,762	-3,237 Reduced 38.42%	5,189 $1.2 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $577,037 - $746,393	3,196 Added 61.11%	8,426 $1.93 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $355,259 - $459,900	2,162 Added 70.47%	5,230 $977,000
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $24,787 - $32,799	190 Added 6.6%	3,068 $518,000
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $13,744 - $15,898	-94 Reduced 3.16%	2,878 $426,000
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $405,440 - $487,942	2,972 New	2,972 $488,000
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $199,754 - $233,163	-1,803 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$111.31 - $131.02 $190,451 - $224,175	1,711 Added 1859.78%	1,803 $234,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $310,109 - $365,021	-2,786 Reduced 96.8%	92 $234,000
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $3,600 - $4,033	-34 Reduced 1.17%	2,878 $333,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $86,375 - $107,953	1,006 Added 52.78%	2,912 $312,000
Q2 2018 Aug 15, 2018	SELL	$75.7 - $86.88 $2.25 Million - $2.58 Million	-29,751 Reduced 93.98%	1,906 $163,000
Q2 2018 Aug 15, 2018	SELL	$75.7 - $86.88 $1.68 Million - $1.93 Million	-22,228 Reduced 41.25%	31,657 $163,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $3.97 Million - $4.56 Million	52,430 Added 3603.44%	53,885 $272,000
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $37,327 - $44,062	503 Added 52.84%	1,455 $113,000
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $78,006 - $83,671	952	952 $80,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Account

Moneta Group Investment Advisors LLC Eli Lilly & CO Transaction History